Form 8-K - Current report:
SEC Accession No. 0000950170-25-106932
Filing Date
2025-08-12
Accepted
2025-08-12 08:06:45
Documents
11
Period of Report
2025-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K coya-20250812.htm   iXBRL 8-K 46995
2 EX-99.1 coya-ex99_1.htm EX-99.1 285433
  Complete submission text file 0000950170-25-106932.txt   459059

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT coya-20250812.xsd EX-101.SCH 26034
13 EXTRACTED XBRL INSTANCE DOCUMENT coya-20250812_htm.xml XML 4929
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)